ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers

Pharmacological Research ◽

10.1016/j.phrs.2017.04.022 ◽

2017 ◽

Vol 121 ◽

pp. 202-212 ◽

Author(s):

Robert Roskoski

Keyword(s):

Fusion Protein ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Protein Tyrosine Kinase ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Lung Cancers ◽

Protein Tyrosine

Download Full-text

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

Cancer Science ◽

10.1111/cas.14801 ◽

2021 ◽

Author(s):

Hiromi Watanabe ◽

Eiki Ichihara ◽

Hiroe Kayatani ◽

Go Makimoto ◽

Kiichiro Ninomiya ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Oncogenic Signaling ◽

Download Full-text

MERTK Promotes Resistance to Irreversible EGFR Tyrosine Kinase Inhibitors in Non–small Cell Lung Cancers Expressing Wild-type EGFR Family Members

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-18-0040 ◽

2018 ◽

Vol 24 (24) ◽

pp. 6523-6535 ◽

Author(s):

Dan Yan ◽

Rebecca E. Parker ◽

Xiaodong Wang ◽

Stephen V. Frye ◽

H. Shelton Earp ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Wild Type ◽

Small Cell Lung ◽

Lung Cancers ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors ◽

Download Full-text

Role of RET protein-tyrosine kinase inhibitors in the treatment RET-driven thyroid and lung cancers

Pharmacological Research ◽

10.1016/j.phrs.2017.12.021 ◽

2018 ◽

Vol 128 ◽

pp. 1-17 ◽

Author(s):

Robert Roskoski ◽

Abdollah Sadeghi-Nejad

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Protein Tyrosine Kinase ◽

Kinase Inhibitors ◽

Lung Cancers ◽

Protein Tyrosine

Download Full-text

Genetic alterations and protein expression in combined small cell lung cancers and small cell lung cancers arising from lung adenocarcinomas after therapy with tyrosine kinase inhibitors

10.18632/oncotarget.9083 ◽

2016 ◽

Vol 7 (23) ◽

pp. 34240-34249 ◽

Author(s):

Xiaohua Shi ◽

Huanli Duan ◽

Xuguang Liu ◽

Liangrui Zhou ◽

Zhiyong Liang

Keyword(s):

Protein Expression ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Genetic Alterations ◽

Small Cell Lung ◽

Lung Cancers ◽

Lung Adenocarcinomas

Download Full-text

Progression patterns after EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutated (EGFR-mut+) non small cell lung cancers (NSCLCs): Correlations with clinical oucomes.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e20600 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e20600-e20600

Author(s):

Alessandro Russo ◽

Valeria Smiroldo ◽

Fabio Raiti ◽

Tindara Franchina ◽

Giuseppa Ferraro ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Lung Cancers ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors ◽

Egfr Mutated ◽

Progression Patterns

Download Full-text

The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials

Lung Cancer ◽

10.1016/j.lungcan.2016.10.004 ◽

2016 ◽

Vol 102 ◽

pp. 21-27 ◽

Author(s):

Bob T. Li ◽

Tristan A. Barnes ◽

David L. Chan ◽

Jarushka Naidoo ◽

Adrian Lee ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Randomized Trials ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Small Cell Lung ◽

Download Full-text

Heterogeneous Response to First-Generation Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancers with Different EGFR Exon 19 Mutations

Targeted Oncology ◽

10.1007/s11523-020-00722-0 ◽

2020 ◽

Vol 15 (3) ◽

pp. 357-364

Author(s):

Haiyan Xu ◽

Weihua Li ◽

Guangjian Yang ◽

Junling Li ◽

Lu Yang ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

First Generation ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Lung Cancers ◽

Download Full-text

Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.

Case Medical Research ◽

10.31525/ct1-nct03958565 ◽

2019 ◽

Author(s):

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Driver Mutations ◽

Small Cell Lung ◽

Lung Cancers ◽

Bony Metastasis

Download Full-text

Neoadjuvant treatment with tyrosine kinase inhibitors in patients with resectable non-small cell lung cancer

Journal of Thoracic Disease ◽

10.21037/jtd.2019.09.68 ◽

2019 ◽

Vol 11 (10) ◽

pp. 4092-4095

Author(s):

Fernando Franco ◽

Mariano Provencio

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Neoadjuvant Treatment ◽

Small Cell Lung

Download Full-text

Use of tyrosine kinase inhibitors during pregnancy for oncogenic-driven advanced non-small cell lung carcinoma

Lung Cancer ◽

10.1016/j.lungcan.2021.09.001 ◽

2021 ◽

Author(s):

Boudy Anne-Sophie ◽

Grausz Noémie ◽

Selleret Lise ◽

Gligorov Joseph ◽

Thomassin-Naggara Isabelle ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Lung Carcinoma ◽

Kinase Inhibitors ◽

Small Cell Lung Carcinoma ◽

Small Cell Lung ◽

Cell Lung Carcinoma

Download Full-text